David Gionco

David Gionco has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Stemline Therapeutics Inc and Savient Pharmaceuticals Inc. Between 27 February 2009 and 10 June 2020, the trades on record add up to 63 filings.

The open-market record consists of 40 sales worth €1.2M, with no purchase. Other entries cover 21 share grants and 1 option exercise. In 2020 alone, the filings show no purchases and 9 sales.

Most recently, on 10 June 2020, the filings show a transaction in Stemline Therapeutics Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.